Same ingredient, two names · tirzepatide

Mounjaro vs Zepbound

From the two FDA labels, read Published by PepVault

Mounjaro and Zepbound are the same medicine, tirzepatide, under two names from Eli Lilly.

What differs is the label. FDA approved Mounjaro for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes. Zepbound is approved for weight loss and keeping it off, and obstructive sleep apnea in adults with obesity.

Label against label

Mounjaro and Zepbound, from their FDA labels and Drugs@FDA
ComparedMounjaroZepbound
Active ingredienttirzepatidetirzepatide
ClassGIP and GLP-1 receptor agonistGIP and GLP-1 receptor agonist
MakerEli LillyEli Lilly
Approved forType 2 diabetes (adults and children 10 and up); heart riskWeight reduction; obstructive sleep apnea with obesity
FormsSingle-dose pen or vial; Multi-dose vial or KwikPenSingle-dose pen or vial; Multi-dose vial or KwikPen
How oftenonce a weekonce a week
Starting dose2.5 mg a week2.5 mg a week
Top dose on the label15 mg a week15 mg a week
Most reported side effectNausea, 18% on 15 mg (placebo 4%)Nausea, 28% on 15 mg (placebo 8%)
Boxed warning“RISK OF THYROID C-CELL TUMORS”“RISK OF THYROID C-CELL TUMORS”
First approved20222023

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Mounjaro, once a week

2.5 mg5 mgif needed7.5 mgif needed10 mgif needed12.5 mgif needed15 mgif needed
Mounjaro’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Zepbound, once a week

2.5 mg5 mg7.5 mgif needed10 mgif needed12.5 mgif needed15 mgif needed
Zepbound’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.
A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

A missed dose, on each label

  • Mounjaro: A missed Mounjaro dose can still be given within 4 days (96 hours). After that it is skipped and the next one comes on the usual day.
  • Zepbound: Zepbound’s missed-dose rule gives 4 days (96 hours): within that window the dose is taken as soon as possible; after it, the dose is skipped and the week carries on as usual.

The research on the ingredient

Questions

Are Mounjaro and Zepbound the same drug?

They hold the same active ingredient, tirzepatide, from Eli Lilly. They are approved for different uses and come in different forms and doses.

What are Mounjaro and Zepbound approved for?

Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes. Zepbound is approved for weight loss and keeping it off, and obstructive sleep apnea in adults with obesity.

How often are Mounjaro and Zepbound taken?

Mounjaro is taken once a week, as an injection; Zepbound once a week, as an injection.

What are the dose ranges of Mounjaro and Zepbound?

On their labels, Mounjaro runs 2.5 mg to 15 mg once a week, and Zepbound 2.5 mg to 15 mg once a week. A prescriber sets the actual dose.

What is the most common side effect of Mounjaro and Zepbound?

On Mounjaro’s label: nausea, 18% on 15 mg (placebo 4%). On Zepbound’s: nausea, 28% on 15 mg (placebo 8%).

Sources

PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner. Zepbound is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo